| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.227 | 14.911 | - | 14.703 | 15.316 | 16.165 | 16.591 | 19.400 | 20.491 | 24.458 |
| Total Income - EUR | 16.227 | 14.931 | - | 14.703 | 15.316 | 16.165 | 16.764 | 19.400 | 20.491 | 24.960 |
| Total Expenses - EUR | 14.927 | 8.188 | - | 8.406 | 9.250 | 8.518 | 11.091 | 18.973 | 20.314 | 29.673 |
| Gross Profit/Loss - EUR | 1.300 | 6.742 | - | 6.297 | 6.066 | 7.647 | 5.674 | 427 | 177 | -4.713 |
| Net Profit/Loss - EUR | 813 | 6.416 | - | 5.856 | 5.606 | 7.175 | 5.171 | 93 | -24 | -5.716 |
| Employees | 1 | 1 | - | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Bio Star Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.100 | 3.531 | - | 2.576 | 2.119 | 1.679 | 1.435 | 1.364 | 1.285 | 49.920 |
| Current Assets | 7.484 | 11.156 | - | 14.056 | 17.056 | 12.241 | 7.861 | 11.201 | 8.361 | 4.904 |
| Inventories | 306 | 303 | - | 320 | 369 | 362 | 583 | 611 | 610 | 606 |
| Receivables | 3.766 | 4.351 | - | 4.264 | 3.939 | 4.112 | 4.191 | 4.407 | 4.899 | 695 |
| Cash | 3.412 | 6.502 | - | 9.473 | 12.748 | 7.767 | 3.086 | 6.183 | 2.853 | 3.603 |
| Shareholders Funds | -4.792 | 1.672 | - | 13.822 | 19.161 | 13.941 | 8.897 | 5.353 | 2.886 | -2.845 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 14.601 | 13.237 | - | 3.025 | 225 | 185 | 601 | 7.638 | 7.750 | 58.655 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Bio Star Srl